rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Nicole Onetto

Director

Company insider

Files Form 4 as: Director, Bolt Biotherapeutics; Director, Viracta Therapeutics; Director, Sierra Oncology; Director, Immunogen; Sr. VP & Chief Medical Officer, Zymogenetics.

Every Form 4 they filed

In numbers

Trades disclosed
57
Buys
0
Sells
1
Bought
$0
Sold
$45K
Companies
5
Companies where not an officer
4
First trade
5 Jan 2006
Last trade
10 Jun 2026
Last filed
11 Jun 2026

Companies traded

Where they are an officer
ZymogeneticsOfficer · last 30 Jan 20090 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
BOLT Bolt BiotherapeuticsDirector · Biotechnology · last 10 Jun 20260 buys · 0 sells
Viracta TherapeuticsDirector · last 9 Jun 20220 buys · 0 sells
Sierra OncologyDirector · last 11 Jun 20190 buys · 0 sells
ImmunogenDirector · last 10 Nov 20150 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 11 Jun 2026BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
10 Jun 2026filed 11 Jun 2026BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,393filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—1,393filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,107filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—1,107filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—611filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—611filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,250filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—1,250filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,250filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—1,250filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,100filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—1,100filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,100filing
12 Dec 2025filed 16 Dec 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—1,100filing
27 May 2025filed 2 Jul 2025BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,100 at $0.00filing
12 Jun 2024filed 14 Jun 2024BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—22,000 at $0.00filing
12 Jun 2023filed 14 Jun 2023BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
10 Jun 2022filed 10 Jun 2022BOLT Bolt Biotherapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.